← Browse by Condition
Medical Condition

dlbcl diffuse large b cell lymphoma associated with chronic inflammation

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT06544265 Phase 1
Recruiting

SynKIR-310 for Relapsed/Refractory B-NHL

Enrollment
18 pts
Location
United States
Sponsor
Verismo Therapeutics
View Trial →